Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06005987 · ClinicalTrials.gov registry record · NA
Mobile App Logging for Diabetes in Pregnancy
A NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy, sponsored by Carolyn Zahler-Miller.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06005987 is a NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by Carolyn Zahler-Miller. The registered enrollment target is 40 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06005987, a NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by Carolyn Zahler-Miller.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Conditions Studied
Interventions
- BEHAVIORAL OneTouch Reveal application
Study Locations (1)
Georgia
- Augusta University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06005987
The ClinicalTrials.gov registry entry for NCT06005987 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Carolyn Zahler-Miller, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which OneTouch Reveal application is the first listed.
NCT06005987 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06005987 about?
NCT06005987 is a clinical study titled "Mobile App Logging for Diabetes in Pregnancy". To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
What is the current status of trial NCT06005987?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-01. Estimated completion is 2027-01-01.
What conditions does trial NCT06005987 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Gestational Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT06005987?
The interventions under investigation include: OneTouch Reveal application (BEHAVIORAL).
Who is sponsoring clinical trial NCT06005987?
This trial is sponsored by Carolyn Zahler-Miller, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06005987 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.